Why do COX-2 inhibitors increase risk of cardiovascular events?

被引：10
|
作者：
Frankish, H
机构：
来源：
LANCET | 2002年 / 359卷 / 9315期
关键词：
D O I：
10.1016/S0140-6736(02)08393-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1410 / 1410
页数：1
相关论文
共 50 条
  • [1] Risk of cardiovascular events associated with COX-2 inhibitors
    不详
    [J]. HOSPITAL MEDICINE, 2001, 62 (09): : 577 - 577
  • [2] Cardiovascular events and COX-2 inhibitors
    Singh, G
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (22): : 2810 - 2811
  • [3] Risk of cardiovascular events associated with selective COX-2 inhibitors
    Mukherjee, D
    Nissen, SE
    Topol, EJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (08): : 954 - 959
  • [4] Do Some Inhibitors of COX-2 Increase the Risk of Thromboembolic Events?Linking Pharmacology with Pharmacoepidemiology
    David W.J. Clark
    Deborah Layton
    Saad A.W. Shakir
    [J]. Drug Safety, 2004, 27 : 427 - 456
  • [5] Do some inhibitors of COX-2 increase the risk of thromboembolic events? Linking pharmacology with pharmacoepidemiology
    Clark, DWJ
    Layton, D
    Shakir, SAW
    [J]. DRUG SAFETY, 2004, 27 (07) : 427 - 456
  • [6] COX-2 inhibitors and cardiovascular risk
    Funk, Colin D.
    FitzGerald, Garret A.
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2007, 50 (05) : 470 - 479
  • [7] COX-2 Inhibitors and Cardiovascular Risk
    Cannon, Christopher P.
    Cannon, Paul J.
    [J]. SCIENCE, 2012, 336 (6087) : 1386 - 1387
  • [8] COX-2 inhibitors and risks for cardiovascular events
    Kazuki Takada
    [J]. Arthritis Research & Therapy, 3 (1)
  • [9] Cox-2: where are we in 2003? - Cardiovascular risk and Cox-2 inhibitors
    Debabrata Mukherjee
    Eric J Topol
    [J]. Arthritis Res Ther, 5
  • [10] Selective cyclooxygenase-2 (COX-2) inhibitors and potential risk of cardiovascular events
    Mukherjee, D
    [J]. BIOCHEMICAL PHARMACOLOGY, 2002, 63 (05) : 817 - 821
12345